{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:08:53Z","timestamp":1789834133291,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pain is a common symptom in individuals with neurofibromatosis type 1 (NF1) that often is associated with plexiform neurofibroma (pNF) tumors. To date, no patient-reported outcome measures have been validated specifically to assess pNF-related pain intensity or pain interference in this population. Such measures are sorely needed since pain is being considered as an outcome in clinical trials targeting reduction of pNF. The study aims were to: (1) obtain qualitative information from individuals with NF1 and pNFs about their pain and its measurement and (2) modify existing scales to assess pNF-related pain intensity and pain interference for NF1 clinical trials.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>For this multi-site, qualitative study, 56 individuals (26 children, 6\u201316 years; 30 adults, 18\u201368 years) with NF1 and pNF participated in a focus group and\/or individual interview about pain intensity and pain interference (concept elicitation) and also provided feedback about existing pain measures (Numeric Rating Scale-11 and Pain Interference Index) assessing these domains (cognitive debriefing). Four additional waves of cognitive debriefing interviews further refined the measures. Qualitative concept elicitation data from transcripts were coded, analyzed using NVivo software, and thematic analysis was conducted using both deductive and inductive techniques. Additional themes and systematic problems and suggestions regarding the measures were gleaned from reviewing the field notes and interview transcriptions generated by the cognitive debriefing sessions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Concept elicitation themes included descriptions of two types of pNF-related pain (chronic and episodic), variability of pain over time, varying ability to recall pain, lack of knowledge of pNFs, and the ways pain interferes with daily activities. Cognitive debriefing themes included information on how to rate pNF-related pain intensity apart from other pain; problems and suggestions regarding the measures included difficulty comprehending some items and preferences for alternative wording and formatting. Based on these qualitative results, the measures\u2019 instructions, items, and formatting were modified to create the PAin INtensity Scale for plexiform neurofibromas (PAINS-pNF) and the Pain Interference Index for plexiform neurofibromas (PII-pNF) for administration on a mobile app or web-based platform.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The PAINS-pNF and PII-pNF are promising self-report measures developed using patient engagement to evaluate tumor pain intensity and pain interference in NF1 clinical trials. The second phase of the study to provide reliability, validity, and normative data for individuals with NF1 and pNFs ages 8 years and older is underway.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41687-025-00877-2","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T07:48:44Z","timestamp":1745999324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings"],"prefix":"10.1186","volume":"9","author":[{"given":"Nour","family":"Al Ghriwati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Struemph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staci","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Tonsgard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth K.","family":"Schorry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin S.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9319-6281","authenticated-orcid":false,"given":"Pamela L.","family":"Wolters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"15","key":"877_CR1","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","volume":"382","author":"AM Gross","year":"2020","unstructured":"Gross AM, Wolters PL, Dombi E, Baldwin A, Whitcomb P, Fisher MJ, Weiss B, Kim A, Bornhorst M, Shah AC, Martin S, Roderick MC, Pichard DC, Carbonell A, Paul SM, Therrien J, Kapustina O, Heisey K, Clapp DW, Zhang C, Peer CJ, Figg WD, Smith M, Glod J, Blakeley JO, Steinberg SM, Venzon DJ, Doyle LA, Widemann BC (2020) Selumetinib in children with inoperable plexiform neurofibromas. N Engl J Med 382(15):1430\u20131442. https:\/\/doi.org\/10.1056\/NEJMoa1912735","journal-title":"N Engl J Med"},{"key":"877_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.37123","author":"PL Wolters","year":"2015","unstructured":"Wolters PL, Burns KM, Martin S, Baldwin A, Dombi E, Toledo-Tamula MA, Dudley WN, Gillespie A, Widemann BC (2015) Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life. Am J Med Genet A. https:\/\/doi.org\/10.1002\/ajmg.a.37123","journal-title":"Am J Med Genet A"},{"issue":"8","key":"877_CR3","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00381-022-05513-8","volume":"38","author":"X Yang","year":"2022","unstructured":"Yang X, Yoo HK, Amin S, Cheng WY, Sundaresan S, Zhang L, Duh MS (2022) Clinical and humanistic burden among pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma in the USA. Childs Nerv Syst 38(8):1513\u20131522. https:\/\/doi.org\/10.1007\/s00381-022-05513-8","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"877_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/17407745231209224","volume":"21","author":"PL Wolters","year":"2024","unstructured":"Wolters PL, Ghriwati NA, Baker M, Martin S, Berg D, Erickson G, Franklin B, Merker VL, Oberlander B, Reeve S, Rohl C, Rosser T, Vranceanu AM (2024) Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: results from an anonymous online survey. Clin Trials 21(1):73\u201384. https:\/\/doi.org\/10.1177\/17407745231209224","journal-title":"Clin Trials"},{"issue":"4","key":"877_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/ajmg.a.61069","volume":"179","author":"AM Kongkriangkai","year":"2019","unstructured":"Kongkriangkai AM, King C, Martin LJ, Wakefield E, Prada CE, Kelly-Mancuso G, Schorry EK (2019) Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis type 1. Am J Med Genet A 179(4):602\u2013607. https:\/\/doi.org\/10.1002\/ajmg.a.61069","journal-title":"Am J Med Genet A"},{"issue":"1","key":"877_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ajmg.a.37987","volume":"173","author":"JS Lai","year":"2017","unstructured":"Lai JS, Jensen SE, Patel ZS, Listernick R, Charrow J (2017) Using a qualitative approach to conceptualize concerns of patients with neurofibromatosis type 1 associated plexiform neurofibromas (pNF) across the lifespan. Am J Med Genet A 173(1):79\u201387. https:\/\/doi.org\/10.1002\/ajmg.a.37987","journal-title":"Am J Med Genet A"},{"issue":"3","key":"877_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10880-018-9584-5","volume":"26","author":"SE Jensen","year":"2019","unstructured":"Jensen SE, Patel ZS, Listernick R, Charrow J, Lai JS (2019) Lifespan development: symptoms experienced by individuals with neurofibromatosis type 1 associated plexiform neurofibromas from childhood into adulthood. J Clin Psychol Med Settings 26(3):259\u2013270. https:\/\/doi.org\/10.1007\/s10880-018-9584-5","journal-title":"J Clin Psychol Med Settings"},{"issue":"2","key":"877_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/pme.12620","volume":"16","author":"S Martin","year":"2015","unstructured":"Martin S, Nelson Schmitt S, Wolters PL, Abel B, Toledo-Tamula MA, Baldwin A, Wicksell RK, Merchant M, Widemann B (2015) Development and validation of the english pain interference index and pain interference index-Parent report. Pain Med 16(2):367\u2013373. https:\/\/doi.org\/10.1111\/pme.12620","journal-title":"Pain Med"},{"issue":"4","key":"877_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/ard.37.4.378","volume":"37","author":"WW Downie","year":"1978","unstructured":"Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA (1978) Studies with pain rating scales. Ann Rheum Dis 37(4):378\u2013381","journal-title":"Ann Rheum Dis"},{"issue":"7 Suppl 1","key":"877_CR10","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1212\/WNL.0000000000002927","volume":"87","author":"PL Wolters","year":"2016","unstructured":"Wolters PL, Martin S, Merker VL, Tonsgard JH, Solomon SE, Baldwin A, Bergner AL, Walsh K, Thompson HL, Gardner KL, Hingtgen CM, Schorry E, Dudley WN, Franklin B, Collaboration REI (2016) Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials. Neurology 87(7 Suppl 1):S4\u2013S12. https:\/\/doi.org\/10.1212\/WNL.0000000000002927","journal-title":"Neurology"},{"issue":"1\u20132","key":"877_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","volume":"113","author":"RH Dworkin","year":"2005","unstructured":"Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113(1\u20132):9\u201319. https:\/\/doi.org\/10.1016\/j.pain.2004.09.012","journal-title":"Pain"},{"issue":"1","key":"877_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1155\/2009\/259759","volume":"14","author":"CL von Baeyer","year":"2009","unstructured":"von Baeyer CL (2009) Children\u2019s self-report of pain intensity: what we know, where we are headed. Pain Res Manag 14(1):39\u201345","journal-title":"Pain Res Manag"},{"issue":"4","key":"877_CR13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/AAP.0b013e318217a635","volume":"36","author":"I Gilron","year":"2011","unstructured":"Gilron I, Jensen MP (2011) Clinical trial methodology of pain treatment studies: selection and measurement of self-report primary outcomes for efficacy. Reg Anesth Pain Med 36(4):374\u2013381. https:\/\/doi.org\/10.1097\/AAP.0b013e318217a635","journal-title":"Reg Anesth Pain Med"},{"issue":"4","key":"877_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/AJP.0000000000000406","volume":"33","author":"E Castarlenas","year":"2017","unstructured":"Castarlenas E, Jensen MP, von Baeyer CL, Miro J (2017) Psychometric properties of the numerical rating scale to assess Self-Reported pain intensity in children and adolescents: a systematic review. Clin J Pain 33(4):376\u2013383. https:\/\/doi.org\/10.1097\/AJP.0000000000000406","journal-title":"Clin J Pain"},{"issue":"10","key":"877_CR15","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.ejpain.2009.08.006","volume":"13","author":"CL von Baeyer","year":"2009","unstructured":"von Baeyer CL (2009) Numerical rating scale for self-report of pain intensity in children and adolescents: recent progress and further questions. Eur J Pain 13(10):1005\u20131007. https:\/\/doi.org\/10.1016\/j.ejpain.2009.08.006","journal-title":"Eur J Pain"},{"issue":"3","key":"877_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4300\/JGME-D-13-00154.1","volume":"5","author":"GB Willis","year":"2013","unstructured":"Willis GB, Artino AR Jr. (2013) What do our respondents think we\u2019re asking?? Using cognitive interviewing to improve medical education surveys. J Grad Med Educ 5(3):353\u2013356. https:\/\/doi.org\/10.4300\/JGME-D-13-00154.1","journal-title":"J Grad Med Educ"},{"key":"877_CR17","unstructured":"Critical Path Institute, ePRO Consortium (2024) Best practices for electronic implementation of response scales for patient-reported outcome measures. https:\/\/c-path.org\/wp-content\/uploads\/BestPractices2_Response_Scales.pdf. Accessed May 3"},{"key":"877_CR18","unstructured":"Critical Path Institute, ePRO Consortium (2024) Best practices for maximizing electronic data capture options during the development of new patient-reported outcome measures. https:\/\/c-path.org\/wp-content\/uploads\/BestPractices_Maximizing_Data_Capture.pdf. Accessed May 3"},{"key":"877_CR19","unstructured":"Metricwire Inc (2024) www.metricwire.com. Accessed May 3"},{"issue":"2","key":"877_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V (2006) Using thematic analysis in psychology. Qualitative Res Psychol 3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa","journal-title":"Qualitative Res Psychol"},{"key":"877_CR21","volume-title":"The discovery of grounded theory: strategies for qualitative research","author":"B Glaser","year":"1967","unstructured":"Glaser B, Strauss A (1967) The discovery of grounded theory: strategies for qualitative research. Sociology, Mill Valley, CA"},{"issue":"5","key":"877_CR22","doi-asserted-by":"publisher","first-page":"e0232076","DOI":"10.1371\/journal.pone.0232076","volume":"15","author":"G Guest","year":"2020","unstructured":"Guest G, Namey E, Chen M (2020) A simple method to assess and report thematic saturation in qualitative research. PLoS ONE 15(5):e0232076. https:\/\/doi.org\/10.1371\/journal.pone.0232076","journal-title":"PLoS ONE"},{"issue":"3","key":"877_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1177\/1049732317697102","volume":"28","author":"J Phillippi","year":"2018","unstructured":"Phillippi J, Lauderdale J (2018) A guide to field notes for qualitative research: context and conversation. Qual Health Res 28(3):381\u2013388. https:\/\/doi.org\/10.1177\/1049732317697102","journal-title":"Qual Health Res"},{"key":"877_CR24","volume-title":"Analysis of the cognitive interview in questionnaire design","author":"GB Willis","year":"2015","unstructured":"Willis GB (2015) Analysis of the cognitive interview in questionnaire design. Analysis of the cognitive interview in questionnaire design. Oxford University Press, New York, NY, US"},{"key":"877_CR25","unstructured":"US Food and Drug Administration. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims (2009) https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims. Accessed May 3, 2024"},{"issue":"1","key":"877_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jval.2023.10.007","volume":"27","author":"FD Mowlem","year":"2024","unstructured":"Mowlem FD, Elash CA, Dumais KM, Haenel E, O\u2019Donohoe P, Olt J, Kalpadakis-Smith AV, James B, Balestrieri G, Becker K, Newara MC, Kern S, Electronic Clinical Outcome Assessment C (2024) Best practices for the electronic implementation and migration of patient-reported outcome measures. Value Health 27(1):79\u201394. https:\/\/doi.org\/10.1016\/j.jval.2023.10.007","journal-title":"Value Health"},{"issue":"2","key":"877_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jval.2018.09.2842","volume":"22","author":"A Gnanasakthy","year":"2019","unstructured":"Gnanasakthy A, Barrett A, Evans E, D\u2019Alessio D, Romano CD (2019) A review of Patient-Reported outcomes labeling for oncology drugs approved by the FDA and the EMA (2012\u20132016). Value Health 22(2):203\u2013209. https:\/\/doi.org\/10.1016\/j.jval.2018.09.2842","journal-title":"Value Health"},{"issue":"11","key":"877_CR28","doi-asserted-by":"publisher","first-page":"e28915","DOI":"10.2196\/28915","volume":"23","author":"H Yu","year":"2021","unstructured":"Yu H, Yu Q, Nie Y, Xu W, Pu Y, Dai W, Wei X, Shi Q (2021) Data quality of longitudinally collected patient-reported outcomes after thoracic surgery: comparison of paper- and web-based assessments. J Med Internet Res 23(11):e28915. https:\/\/doi.org\/10.2196\/28915","journal-title":"J Med Internet Res"},{"key":"877_CR29","volume-title":"Focus groups: A practical guide for applied research","author":"RA Krueger","year":"2000","unstructured":"Krueger RA, Casey MA (2000) Focus groups: a practical guide for applied research, 3rd edn. Sage, Thousand Oaks, CA","edition":"3"},{"key":"877_CR30","doi-asserted-by":"publisher","DOI":"10.4135\/9781483328171","volume-title":"Planning focus groups. The focus group kit","author":"DL Morgan","year":"1998","unstructured":"Morgan DL (1998) Planning focus groups. The focus group kit. Sage Publising, Thousand Oaks, CA"},{"issue":"2","key":"877_CR31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1365-2648.2007.04559.x","volume":"62","author":"SD Lambert","year":"2008","unstructured":"Lambert SD, Loiselle CG (2008) Combining individual interviews and focus groups to enhance data richness. J Adv Nurs 62(2):228\u2013237. https:\/\/doi.org\/10.1111\/j.1365-2648.2007.04559.x","journal-title":"J Adv Nurs"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00877-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-025-00877-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00877-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T07:48:51Z","timestamp":1745999331000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-025-00877-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["877"],"URL":"https:\/\/doi.org\/10.1186\/s41687-025-00877-2","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research study was approved by the Institutional Review Board of the National Cancer Institute and performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}